Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCP2 | P22307 | 1/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13881978 | 0.92 | SCP2 (0.72) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL12946584 | 0.85 | SCP2 (0.57) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL12949057 | 0.84 | SCP2 (0.57) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL23407860 | 0.81 | SCP2 (0.57) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL26434988 | 0.80 | SCP2 (0.75) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL23407835 | 0.80 | SCP2 (0.51) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL16327768 | 0.80 | SCP2 (0.49) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL26434823 | 0.79 | SCP2 (0.76) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL3501312 | 0.79 | SCP2 (0.82) | SCP2GPR84POLBMEN1NPC1 | |
| SCHEMBL13881728 | 0.79 | SCP2 (0.49) | SCP2GPR84POLBMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| WO-2009043899-A1 | DRUG TRANSFER INTO LIVING CELLS | COVALYS BIOSCIENCES AG (CH) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009043900-A1 | DRUG TRANSFER BASED ON COENZYME A AND ACYL CARRIER PROTEIN | COVALYS BIOSCIENCES AG (CH) | 2009-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014196-A1 | Drug Transfer into Living Cells | TSPO, MPI, ABCB1 | SCP2 789/4885GPR84 1274/4885POLB 3741/4885 |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COASY, ACAT2, ACAT1 | SCP2 71/4885GPR84 735/4885POLB 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.